Shaolin Ma

735 total citations
32 papers, 363 citations indexed

About

Shaolin Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shaolin Ma has authored 32 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Shaolin Ma's work include MicroRNA in disease regulation (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Respiratory Support and Mechanisms (3 papers). Shaolin Ma is often cited by papers focused on MicroRNA in disease regulation (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Respiratory Support and Mechanisms (3 papers). Shaolin Ma collaborates with scholars based in China, United States and Hong Kong. Shaolin Ma's co-authors include Liwu Fu, Cristina Ivan, Anil K. Sood, Gabriel Lopez‐Berestein, Fang Wang, Lingegowda S. Mangala, Cristian Rodriguez‐Aguayo, Emine Bayraktar, Zhe‐Sheng Chen and Robert L. Coleman and has published in prestigious journals such as Cancer Research, Oncogene and British Journal of Pharmacology.

In The Last Decade

Shaolin Ma

29 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaolin Ma China 11 199 123 75 42 27 32 363
Joana Márquez Spain 13 174 0.9× 115 0.9× 83 1.1× 70 1.7× 21 0.8× 26 373
Lei Lou China 13 274 1.4× 80 0.7× 97 1.3× 39 0.9× 26 1.0× 35 431
Iryna Kolosenko Sweden 11 237 1.2× 116 0.9× 91 1.2× 68 1.6× 18 0.7× 19 383
Quanyi Lu China 11 270 1.4× 69 0.6× 117 1.6× 31 0.7× 31 1.1× 52 425
Agnès Basseville United States 11 321 1.6× 239 1.9× 56 0.7× 39 0.9× 27 1.0× 18 521
Saptarshi Sinha India 13 233 1.2× 194 1.6× 49 0.7× 58 1.4× 17 0.6× 23 410
Yolla Haibe Lebanon 8 196 1.0× 155 1.3× 106 1.4× 49 1.2× 31 1.1× 15 404
Jae Hong Seo South Korea 12 180 0.9× 161 1.3× 66 0.9× 25 0.6× 43 1.6× 16 392
Kailiang Zhao China 10 182 0.9× 117 1.0× 73 1.0× 54 1.3× 15 0.6× 38 354

Countries citing papers authored by Shaolin Ma

Since Specialization
Citations

This map shows the geographic impact of Shaolin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaolin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaolin Ma more than expected).

Fields of papers citing papers by Shaolin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaolin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaolin Ma. The network helps show where Shaolin Ma may publish in the future.

Co-authorship network of co-authors of Shaolin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shaolin Ma. A scholar is included among the top collaborators of Shaolin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaolin Ma. Shaolin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yang, et al.. (2025). The value of heparin-binding protein in bronchoalveolar lavage fluid in acute respiratory distress syndrome. Frontiers in Medicine. 12. 1537680–1537680. 1 indexed citations
2.
Wu, Jingxiang, Dongdong Ye, Shaolin Ma, et al.. (2024). New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer. BMC Cancer. 24(1). 1536–1536.
3.
4.
5.
Ma, Shaolin, Li‐ping Gong, Yuhang Pan, et al.. (2024). PPM1G promotes cell proliferation via modulating mutant GOF p53 protein expression in hepatocellular carcinoma. iScience. 27(3). 109116–109116. 1 indexed citations
6.
7.
Zhou, Wei, Zhen Du, Tao Yun, et al.. (2023). Effect of preoperative pulmonary artery pressure on the prognosis of end-stage heart failure patients after heart transplantation. Journal of Cardiothoracic Surgery. 18(1). 154–154. 2 indexed citations
8.
Liu, Peng, Shaolin Ma, Guixiang Du, et al.. (2021). Changing Paradigm for Vertigo/Dizziness Patients: a Retrospective Before-After Study from Tertiary Hospitals in Northwestern China. Journal of General Internal Medicine. 36(10). 3064–3070. 3 indexed citations
9.
Ma, Shaolin, Michael H. McGuire, Lingegowda S. Mangala, et al.. (2021). Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype. Cell Reports. 34(6). 108726–108726. 33 indexed citations
10.
Wu, Yutuan, Jie Huang, Cristina Ivan, et al.. (2021). MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer. Gynecologic Oncology. 163(1). 181–190. 12 indexed citations
11.
Ma, Shaolin, Anca Chelariu-Raicu, Carola Leuschner, et al.. (2020). Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer. Molecular Cancer Therapeutics. 19(11). 2396–2406. 15 indexed citations
12.
Ma, Shaolin, Sunila Pradeep, Alejandro Villar‐Prados, et al.. (2019). GnRH-R–Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition. Molecular Cancer Therapeutics. 18(5). 969–979. 13 indexed citations
13.
Zhao, Zhongfang, et al.. (2019). Anti-melanogenesis Efficacy of Ginkgolide B is Favored by Attenuating Oxidative Stress and Melanin Synthesis in B16f1 Melanoma Cell Model. International Journal of Pharmacology. 15(5). 560–566. 4 indexed citations
14.
Villar‐Prados, Alejandro, Sherry Y. Wu, Karem A. Court, et al.. (2018). Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4. Molecular Cancer Therapeutics. 18(2). 421–436. 10 indexed citations
15.
Liu, Yang, Shaolin Ma, Xuebin Wang, et al.. (2018). The role of β2 integrin associated heparin-binding protein release in ARDS. Life Sciences. 203. 92–98. 9 indexed citations
16.
Mitamura, Takashi, Sunila Pradeep, Michael H. McGuire, et al.. (2017). Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). Oncogene. 37(6). 722–731. 40 indexed citations
17.
Wang, Yanli, et al.. (2015). Antitumor activity of gambogic acid on NCI-H1993 xenografts via MET signaling pathway downregulation. Oncology Letters. 10(5). 2802–2806. 11 indexed citations
18.
Zhang, Hui, Atish Patel, Shaolin Ma, et al.. (2014). In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1. British Journal of Pharmacology. 171(24). 5845–5857. 45 indexed citations
19.
Wang, Xuebin, et al.. (2014). Effects and Mechanism Analysis of Combined Infusion by Levosimendan and Vasopressin on Acute Lung Injury in Rats Septic Shock. Cell Biochemistry and Biophysics. 70(3). 1639–1645. 8 indexed citations
20.
Ma, Shaolin. (2012). Mechanical ventilation and diaphragmatic atrophy. Chinese Journal of Asthma. 32(1). 70–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joana Márquez Breakdown of academic impact, for papers by Lei Lou Breakdown of academic impact, for papers by Iryna Kolosenko Breakdown of academic impact, for papers by Quanyi Lu Breakdown of academic impact, for papers by Agnès Basseville Breakdown of academic impact, for papers by Saptarshi Sinha Breakdown of academic impact, for papers by Yolla Haibe Breakdown of academic impact, for papers by Jae Hong Seo Breakdown of academic impact, for papers by Kailiang Zhao
Rankless by CCL
2026